CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL

NCT00576225 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

NSCLC

Interventions

DRUG: CT-2103/carboplatin
DRUG: paclitaxel/carboplatin

Sponsor

CTI BioPharma